# FDA Inspection 1122884 - Mylan Laboratories Limited (FDF-2) - February 28, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/da22dd0f-6306-46da-8000-97facc10196d
Source feed: FDA_Inspections

> FDA Inspection 1122884 for Mylan Laboratories Limited (FDF-2) on February 28, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122884
- Company Name: Mylan Laboratories Limited (FDF-2)
- Inspection Date: 2020-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1253435 - 2023-02-03](https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/c86b2c6d-3939-43ca-9c49-3ab1f5c1b33f)
- [FDA Inspection 1091217 - 2019-04-26](https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/42de1dba-0b73-460b-9dc0-5c883cb0d514)
- [FDA Inspection 1012796 - 2017-05-26](https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/c3b3d8ef-b5cf-4868-ab95-1933bf124403)
- [FDA Inspection 884211 - 2014-05-16](https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/53ebc2c6-eeb9-4b2d-8a99-ac4237992fe3)
- [FDA Inspection 775616 - 2012-03-09](https://www.globalkeysolutions.net/records/fda_inspections/mylan-laboratories-limited-fdf-2/fff7282c-5b9b-4473-9f22-67a98b04d40c)

Company: https://www.globalkeysolutions.net/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c